Suppr超能文献

多中心应用顺行开窗和再进入技术开通慢性完全闭塞病变的经验。

Multicenter experience with the antegrade fenestration and reentry technique for chronic total occlusion recanalization.

机构信息

The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Division of Interventional Cardiology, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy.

出版信息

Catheter Cardiovasc Interv. 2021 Jan 1;97(1):E40-E50. doi: 10.1002/ccd.28941. Epub 2020 Apr 22.

Abstract

OBJECTIVES

We aimed to evaluate the efficacy and safety of antegrade fenestration and reentry (AFR) for chronic total occlusion (CTO) recanalization in a multicenter registry.

BACKGROUND

Adoption of antegrade dissection/reentry (ADR) for CTO recanalization has been limited, and novel ADR techniques are needed.

METHODS

AFR involves the balloon-induced creation of multiple fenestrations between the false and true lumen. A targeted true lumen reentry is subsequently achieved with a low tip-load polymer-jacketed guidewire. Following the initial description and dissemination of AFR, patients undergoing AFR-based CTO recanalization at nine centers were included in the present registry. Study endpoints were AFR success, procedural success, and target-lesion failure (TLF) on follow-up.

RESULTS

We included 41 patients. Mean J-CTO score was 2.5 ± 1.4. In 80.5% of cases, AFR was performed after failed antegrade wire escalation. Another ADR technique was used before AFR in one-third of cases. AFR achieved distal true lumen reentry in n = 27/41 (65.9%) cases. In n = 14/41 (34.1%) cases with AFR failure, use of alternative techniques led to successful CTO recanalization in eight additional patients. The overall technical and procedural success rates were 85.4% and 82.9%, respectively. No AFR-related complications were observed. One-year TLF rate was 8.3% overall, with no differences between successful and failed AFR.

CONCLUSIONS

We report on AFR feasibility in a multicenter registry of patients undergoing CTO recanalization. We observed a moderate success rate, coupled with the absence of complications. Moreover, even a failed AFR attempt did not preclude the use of alternative techniques to achieve recanalization. Further studies should confirm and extend our findings.

摘要

目的

我们旨在评估多中心注册研究中顺行开窗和再进入(AFR)治疗慢性完全闭塞(CTO)再通的疗效和安全性。

背景

采用顺行夹层/再进入(ADR)治疗 CTO 再通的方法受到限制,需要新的 ADR 技术。

方法

AFR 涉及在假腔和真腔之间用球囊诱导产生多个窗孔。随后,用低尖端负荷聚合物护套导丝实现靶向真腔再进入。在 AFR 的初步描述和传播之后,在九个中心进行基于 AFR 的 CTO 再通的患者被纳入本注册研究。研究终点为 AFR 成功、程序成功和随访期间的靶病变失败(TLF)。

结果

我们纳入了 41 名患者。平均 J-CTO 评分 2.5±1.4。80.5%的病例在顺行导丝升级失败后进行 AFR。三分之一的病例在进行 AFR 前使用了另一种 ADR 技术。在 n = 27/41(65.9%)病例中,AFR 实现了远端真腔再进入。在 n = 14/41(34.1%)的 AFR 失败病例中,使用替代技术使另外 8 例患者成功再通 CTO。总的技术和程序成功率分别为 85.4%和 82.9%。未观察到与 AFR 相关的并发症。总的 1 年 TLF 率为 8.3%,成功和失败的 AFR 之间没有差异。

结论

我们报告了多中心注册研究中接受 CTO 再通的患者中 AFR 的可行性。我们观察到中等成功率,且无并发症。此外,即使 AFR 尝试失败,也不排除使用替代技术来实现再通。进一步的研究应该证实并扩展我们的发现。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验